141 related articles for article (PubMed ID: 22975515)
1. 9,10-phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3.
Matsunaga T; Hosogai M; Arakaki M; Endo S; El-Kabbani O; Hara A
Biol Pharm Bull; 2012; 35(9):1598-602. PubMed ID: 22975515
[TBL] [Abstract][Full Text] [Related]
2. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells.
Matsunaga T; Arakaki M; Kamiya T; Endo S; El-Kabbani O; Hara A
Chem Biol Interact; 2009 Sep; 181(1):52-60. PubMed ID: 19442656
[TBL] [Abstract][Full Text] [Related]
3. 9,10-Phenanthrenequinone promotes secretion of pulmonary aldo-keto reductases with surfactant.
Matsunaga T; Haga M; Watanabe G; Shinoda Y; Endo S; Kajiwara Y; Tanaka H; Inagaki N; El-Kabbani O; Hara A
Cell Tissue Res; 2012 Feb; 347(2):407-17. PubMed ID: 22281686
[TBL] [Abstract][Full Text] [Related]
4. An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies.
Byrns MC; Steckelbroeck S; Penning TM
Biochem Pharmacol; 2008 Jan; 75(2):484-93. PubMed ID: 17950253
[TBL] [Abstract][Full Text] [Related]
5. Aldo-keto reductase 1C15 as a quinone reductase in rat endothelial cell: its involvement in redox cycling of 9,10-phenanthrenequinone.
Matsunaga T; Shinoda Y; Inoue Y; Shimizu Y; Haga M; Endo S; El-Kabbani O; Hara A
Free Radic Res; 2011 Jul; 45(7):848-57. PubMed ID: 21623689
[TBL] [Abstract][Full Text] [Related]
6. L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.
Matsunaga T; Kamiya T; Sumi D; Kumagai Y; Kalyanaraman B; Hara A
Free Radic Biol Med; 2008 Mar; 44(6):1191-202. PubMed ID: 18206670
[TBL] [Abstract][Full Text] [Related]
7. Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells.
Matsunaga T; Yamaguchi A; Morikawa Y; Kezuka C; Takazawa H; Endo S; El-Kabbani O; Tajima K; Ikari A; Hara A
Anticancer Drugs; 2014 Sep; 25(8):868-77. PubMed ID: 24743520
[TBL] [Abstract][Full Text] [Related]
8. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
Matsunaga T; Morikawa Y; Haga M; Endo S; Soda M; Yamamura K; El-Kabbani O; Tajima K; Ikari A; Hara A
Toxicol Appl Pharmacol; 2014 Jul; 278(2):180-9. PubMed ID: 24813866
[TBL] [Abstract][Full Text] [Related]
9. NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory Macrophages.
Song MG; Ryoo IG; Choi HY; Choi BH; Kim ST; Heo TH; Lee JY; Park PH; Kwak MK
PLoS One; 2015; 10(7):e0134235. PubMed ID: 26222138
[TBL] [Abstract][Full Text] [Related]
10. The role of aldo-keto reductase 1C3 (AKR1C3)-mediated prostaglandin D2 (PGD2) metabolism in keloids.
Mantel A; Newsome A; Thekkudan T; Frazier R; Katdare M
Exp Dermatol; 2016 Jan; 25(1):38-43. PubMed ID: 26308156
[TBL] [Abstract][Full Text] [Related]
11. N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.
Sinreih M; Sosič I; Beranič N; Turk S; Adeniji AO; Penning TM; Rižner TL; Gobec S
Bioorg Med Chem Lett; 2012 Sep; 22(18):5948-51. PubMed ID: 22897946
[TBL] [Abstract][Full Text] [Related]
12. Facilitation of 9,10-phenanthrenequinone-elicited neuroblastoma cell apoptosis by NAD(P)H:quinone oxidoreductase 1.
Matsunaga T; Kamase K; Takasawa H; Yamaji Y; Endo S; El-Kabbani O; Ikari A
Chem Biol Interact; 2018 Jan; 279():10-20. PubMed ID: 29108775
[TBL] [Abstract][Full Text] [Related]
13. Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.
Mantel A; Carpenter-Mendini AB; Vanbuskirk JB; De Benedetto A; Beck LA; Pentland AP
J Invest Dermatol; 2012 Apr; 132(4):1103-10. PubMed ID: 22170488
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.
Lemarie A; Morzadec C; Mérino D; Micheau O; Fardel O; Vernhet L
J Pharmacol Exp Ther; 2006 Jan; 316(1):304-14. PubMed ID: 16174796
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mitigates apoptosis in human endothelial cells induced by 9,10-phenanthrenequinone: role of proteasomal function.
Matsunaga T; Arakaki M; Kamiya T; Haga M; Endo S; El-Kabbani O; Hara A
Toxicology; 2010 Feb; 268(3):191-7. PubMed ID: 20026164
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.
Tian Y; Zhao L; Wang Y; Zhang H; Xu D; Zhao X; Li Y; Li J
Asian J Androl; 2016; 18(4):607-12. PubMed ID: 26698234
[TBL] [Abstract][Full Text] [Related]
17. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells.
Zhao J; Xiang Y; Xiao C; Guo P; Wang D; Liu Y; Shen Y
Int J Med Sci; 2014; 11(11):1089-97. PubMed ID: 25170291
[TBL] [Abstract][Full Text] [Related]
18. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
19. Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.
Mantel A; Carpenter-Mendini A; VanBuskirk J; Pentland AP
Exp Dermatol; 2014 Aug; 23(8):573-8. PubMed ID: 24917395
[TBL] [Abstract][Full Text] [Related]
20. Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.
Pippione AC; Giraudo A; Bonanni D; Carnovale IM; Marini E; Cena C; Costale A; Zonari D; Pors K; Sadiq M; Boschi D; Oliaro-Bosso S; Lolli ML
Eur J Med Chem; 2017 Oct; 139():936-946. PubMed ID: 28881288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
